Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation

EClinicalMedicine

Vibe Skov¹  Lasse Kjær²  Charlotte Liisborg³  Hans Carl Hasselbalch⁴  Torben Lykke Sørensen⁴ 

[1] Department of Ophthalmology, Zealand University Hospital, Vestermarksvej 23, Roskilde DK-4000, Denmark;Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, Copenhagen 2200, Denmark;Corresponding author.;Department of Haematology, Zealand University Hospital, Vestermarksvej 15-17, Roskilde 4000, Denmark;

关键词: Myeloproliferative neoplasms;    “Human inflammation model”;    Biological continuum;    Age-related macular degeneration;    Chronic low-grade inflammation;    Complement dysregulation;   

DOI  :  

来源: DOAJ

【 摘 要 】

Summary:Background: The hematopoietic stem cell disorders, myeloproliferative neoplasms (MPNs), are characterised by chronic low-grade inflammation (CLI). Recently, we showed that patients with MPNs have an increased prevalence of drusen and age-related macular degeneration (AMD), and drusen prevalence seemed associated with higher CLI. Studying MPNs may reveal more about drusen pathophysiology. This study investigated CLI further by measuring cytokine levels and complement system markers, comparing these between patients with MPNs and AMD. Methods: This cross-sectional study, between July 2018 and November 2020 conducted at Zealand University Hospital (ZUH) – Roskilde, Denmark, included 29 patients with neovascular AMD (nAMD), 28 with intermediate-stage AMD (iAMD), 62 with MPNs (35 with drusen - MPNd and 27 with healthy retinas - MPNn). With flow cytometry, we measured complement-regulatory-proteins (Cregs). With immunoassays, we investigated cytokine levels combined into a summary-inflammation-score (SIS). Findings: The MPNd and nAMD groups had similar SIS, significantly higher than the MPNn and iAMD groups. Additionally, we found SIS to increase over the MPN biological continuum from early cancer stage, essential thrombocytaemia (ET), over polycythaemia vera (PV) to the late-stage primary myelofibrosis (PMF). MPNs showed signs of complement dysregulation, with Cregs expression lower in PV than ET and PMF and even lower in PV patients with drusen. Interpretation: This study suggests that MPNd have a higher CLI than MPNn and may indicate systemic CLI to play a greater part in, and even initiate drusen formation. We suggest using MPNs as a “Human Inflammation Model” of drusen development. The CLI in MPNs elicits drusen formation, triggering more CLI creating a vicious cycle, increasing the risk of developing AMD. Funding: Fight for Sight, Denmark, and Region Zealand's research promotion fund.

【 授权许可】

Unknown